| |
|
|
|
Oasmia Pharmaceu Ads
|
|
1.05 +0.01 (+0.96%) |
8/23/2017 3:33pm |
|
Open: |
1.07 |
Pre close: |
1.04 |
Target:
|
1.33
|
|
High: |
1.07 |
Low: |
1.05 |
Resistance:
|
1.14
1.32
|
|
Volume: |
600 |
Market Cap: |
44.13M |
Support:
|
0.85
0.71
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.05
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
1.05  |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.52 |
Stochastic Oscillator |
%K(14,3):
|
39.46 |
|
MA(250): |
2.28 |
%D(3): |
40.88 |
|
Average Volume(K) |
3-Month: |
1212
|
52-Week |
High:
|
3.70 |
|
10-Days: |
53 |
Low: |
0.85 |
|
RSI |
RSI(14):
|
48.23 |
Change(%): |
-66.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-51.2 |
Shares Out. (M) |
126.10 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-17.0 |
Shares Float (M) |
29.48 |
|
EPS Est. Next Year |
-0.330 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-9.8 |
% Held by Institutions |
0.00 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.002 |
Shares Short (K) |
30 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.132 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-16.27 |
P/S |
6620249600.00 |
|
Operating Margin |
-1955.29 |
Levered Free Cash Flow
(M) |
-8.89 |
P/CF |
-8.14 |
|
|
|
|
|
|
|
